Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Melanoma Institute Australia
Dana-Farber Cancer Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
University of Washington
ImmunityBio, Inc.
M.D. Anderson Cancer Center
Mayo Clinic